100 related articles for article (PubMed ID: 11044810)
1. Multiple conformational epitopes are recognized by natural and induced immunity to the E7 protein of human papilloma virus type 16 in man.
Malcolm K; Meschede W; Pawlita M; Koutsky LA; Frazer IH
Intervirology; 2000; 43(3):165-73. PubMed ID: 11044810
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
[TBL] [Abstract][Full Text] [Related]
4. Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients.
Stacey SN; Ghosh A; Bartholomew JS; Tindle RW; Stern PL; Mackett M; Arrand JR
J Med Virol; 1993 May; 40(1):14-21. PubMed ID: 7685808
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.
Nilges K; Höhn H; Pilch H; Neukirch C; Freitag K; Talbot PJ; Maeurer MJ
J Virol; 2003 May; 77(9):5464-74. PubMed ID: 12692247
[TBL] [Abstract][Full Text] [Related]
6. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
[TBL] [Abstract][Full Text] [Related]
7. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
9. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
Meschede W; Zumbach K; Braspenning J; Scheffner M; Benitez-Bribiesca L; Luande J; Gissmann L; Pawlita M
J Clin Microbiol; 1998 Feb; 36(2):475-80. PubMed ID: 9466762
[TBL] [Abstract][Full Text] [Related]
11. Detection of human antibody against the human papillomavirus type 16 E7 protein.
Hashido M; Kanda T; Zanma S; Watanabe S; Komiyama N; Yoshikawa H; Yamaguchi N; Kawana T; Yoshiike K
Jpn J Cancer Res; 1991 Dec; 82(12):1406-12. PubMed ID: 1663920
[TBL] [Abstract][Full Text] [Related]
12. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
Jochmus I; Osen W; Altmann A; Buck G; Hofmann B; Schneider A; Gissmann L; Rammensee HG
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1689-95. PubMed ID: 9225046
[TBL] [Abstract][Full Text] [Related]
13. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
Kadish AS; Timmins P; Wang Y; Ho GY; Burk RD; Ketz J; He W; Romney SL; Johnson A; Angeletti R; Abadi M;
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination.
Suchánková A; Ritterová L; Krcmár M; Krchnák V; Vágner J; Jochmus I; Gissmann L; Kanka J; Vonka V
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2577-81. PubMed ID: 1655964
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papilloma virus type 16 during treatment and follow-up.
Baay MF; Duk JM; Burger MP; de Bruijn HW; Stolz E; Herbrink P
Eur J Clin Microbiol Infect Dis; 1999 Feb; 18(2):126-32. PubMed ID: 10219577
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
[TBL] [Abstract][Full Text] [Related]
17. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
[TBL] [Abstract][Full Text] [Related]
18. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology.
Sehr P; Zumbach K; Pawlita M
J Immunol Methods; 2001 Jul; 253(1-2):153-62. PubMed ID: 11384677
[TBL] [Abstract][Full Text] [Related]
19. HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment.
Di Lonardo A; Marcante ML; Poggiali F; Venuti A
J Med Virol; 1998 Mar; 54(3):192-5. PubMed ID: 9515768
[TBL] [Abstract][Full Text] [Related]
20. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
